Green Cross to emerge as forerunner in vaccine business

Green Cross Corporation (GCC) is expected to become a leader in the new influenza vaccine sector as the Korean government plans to double its stockpile of Tamiflu and other influenza drugs, enough to treat 5 million people, around 10 percent of the country's population, according to a market analyst.

Korea is now studying the WHO standard virus of the influenza, which was offered by the U.S....